Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 13, 2002
Identification and characterization of a novel murine beta-defensin-related geneGillian M Morrison, Mark Rolfe, Fiona M Kilanowski, et al.Journal of Radiology Case Reports|October 21, 2016
Middle Lobe Torsion after Unilateral Lung TransplantChad S Cox, Summer J Decker, Mark Rolfe, et al.Molecular Imaging and Biology|August 10, 2006
Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine modelYumin Zhang, Melissa Saylor, Shenhua Wen, et al.Communications Biology|July 3, 2021
Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platformYifeng Xia, Xiaodong Ji, In Sock Jang, et al.Expert Review of Anticancer Therapy|February 25, 2003
Antibody-based therapeutics in oncologyJeffreys Ross, Karen Gray, David Schenkein, et al.Molecular Cancer Therapeutics|January 24, 2007
The JAMM motif of human deubiquitinase Poh1 is essential for cell viabilityMelissa Gallery, Jonathan L Blank, Yinghui Lin, et al.Molecular Cancer Therapeutics|March 21, 2006
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cellsJordi Codony-Servat, Maria A Tapia, Marta Bosch, et al.The Journal of Biological Chemistry|June 11, 2011
Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90(RSK) in the control of mTORC1 protein signaling by phorbol estersBruno D Fonseca, Tommy Alain, Leona K Finestone, et al.Cancer Metastasis Reviews|January 13, 2006
Antibody-based therapeutics: focus on prostate cancerJeffrey S Ross, Karen E Gray, Iain J Webb, et al.American Journal of Respiratory and Critical Care Medicine|September 21, 2010
RNA interference therapy in lung transplant patients infected with respiratory syncytial virusMartin R Zamora, Marie Budev, Mark Rolfe, et al.Pageof 5